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Ephrin B1 and its cognate receptor, Eph
receptor B2, key regulators of
embryogenesis, are expressed in human
atherosclerotic plaque and inhibit adult
human monocyte chemotaxis. Few data
exist, however, regarding the gene
expression profiles of the ephrin (EFN)
and Eph receptor (EPH) family of genes in
atherosclerosis-related human cells. Gene
expression profiles were determined of all
21 members of this gene family in
atherosclerosis-related cells by reverse
transcription–polymerase chain reaction
analysis. The following 17 members were
detected in adult human peripheral blood
monocytes: EFNA1 and EFNA3 – EFNA5
(coding for ephrins A1 and A3 – A5);
EPHA1, EPHA2, EPHA4 – EPHA6 and
EPHA8 (coding for Eph receptors A1, A2,
A4 – A6 and A8); EFNB1 and EFNB2
(coding for ephrins B1 and B2); and
EPHB1 – EPHB4 and EPHB6 (coding for
Eph receptors B1 – B4 and B6). THP-1
monocytic cells, Jurkat T cells and adult
arterial endothelial cells also expressed
multiple EFN and EPH genes. These results
indicate that a wide variety of ephrins
and Eph receptors might affect monocyte
chemotaxis, contributing to the
development of atherosclerosis. Their
pathological significance requires further
study.
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Introduction
In the development of atherosclerosis,
monocytes transmigrate through the
endothelium and differentiate into
macrophages.1,2 It was previously
demonstrated that ephrin B1 cell signalling
peptide and its cognate receptor, ephrin
receptor B2 (EphB2), which are key
regulators of embryogenesis and
morphogenesis,3,4 are expressed in
atherosclerotic lesions, and that both ephrin
B1 and EphB2 inhibit monocyte
chemotaxis.5 There are few data, however,
on the gene expression profile of the ephrin
(EFN) and Eph receptor (EPH) family of genes
in atherosclerosis-related human cells. The
present study, therefore, analysed the
expression of all 21 members of the EFN and
EPH gene family in adult human monocytes
and related cells. 
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Materials and methods
This study was performed in accordance with
the International Code of Medical Ethics of
the World Medical Association (Declaration
of Helsinki).
CELL PURIFICATION AND CULTURE
Mononuclear cells from venous blood of
healthy adult volunteers were prepared
using Lymphoprep™ (Axis-Shield, Oslo,
Norway). Monocytes were enriched by
counter-flow centrifugal elutriation (R5E
elutriation system; Hitachi Koki, Ibaraki,
Japan) as described previously.5 THP-1
monocytic cells and Jurkat T cells were
purchased from the American Type Culture
Collection (ATCC, Rockville, MD, USA) and
cultured in RPMI medium supplemented
with 10% heat-inactivated fetal bovine
serum at 37 °C in a 5% carbon dioxide
atmosphere. Adult human coronary artery
endothelial cells (HCAEC) were obtained
from the Applied Cell Biology Research
Institute (Kirkland, WA, USA) and
maintained in CSC medium (Applied Cell
Biology Research Institute) at 37 °C in a 5%
carbon dioxide atmosphere. For experiments
with HCAEC cells up to the third passage
were used.
RNA ISOLATION AND RT–PCR
TEMPLATE PREPARATION
Total RNA was isolated from the cells using
Isogen reagent (Nippon Gene, Tokyo,
Japan),5 – 8 and was cleared of genomic DNA
by the use of genomic DNA wipe-out buffer
from the QuantiTect™ Reverse Transcription
Kit (Qiagen, Hilden, Germany). Reverse
transcription–polymerase chain reaction
(RT–PCR) was used in the present study
instead of a microarray9 because of its
specificity. Forward and reverse primers were
designed for particular exons within each
gene using human genomic DNA as the
common positive control template. The
exon–intron structures of all human EFN and
EPH genes were identified through the Map
Viewer Web site (http://www.ncbi.nlm.nih.
gov/mapview/map_search.cgi). The primer
sets used in this study are shown in Table 1.
Ex Taq™ polymerase (TaKaRa, Tokyo, Japan)
was used for PCR and the reaction mixture
was assembled to a total volume of 10 µl as
follows: 6.65 µl water, 1.0 µl 10 × Ex Taq™
buffer, 0.8 µl dNTP mixture (comprising
2.5 mM of each nucleotide), 1.0 µl forward
and reverse primers (5 µM of each primer),
0.5 µl template and 0.05 µl Ex Taq™
polymerase. The PCR was carried out with
pre-heating (94 °C for 2 min) and 30 or 35
cycles of amplification (94 °C for 20 s, 55 °C
or 60 °C for 30 s and 72 °C for 40 s). DNA-
cleared RNA without reverse transcription
and human genomic DNA (50 nM;
Clontech, Palo Alto, CA, USA) were used as
negative and positive control templates,
respectively. For all cell types, PCR was
repeated three to five times and




Each primer set amplified a single PCR
product from genomic DNA (Fig. 1, lane 3 in
each column) and no product from the DNA-
cleared RNA (Fig. 1, lane 2 in each column).
Thus, the RT–PCR products were specific to
the target genes and were derived from the
synthesized cDNA. When expression of the
genes coding for ephrin B1 (EFNB1) and
EphB2 (EPHB2) were examined in human
monocytes, THP-1 cells and HCAEC (Fig. 1),
expression was consistent with our previous
data obtained by RT–PCR using different
primers and an immunofluorescence
technique.5 The present RT–PCR method was,
therefore, reliable for analysis of the
524
A Sakamoto, Y Sugamoto, Y Tokunaga et al.


















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































A Sakamoto, Y Sugamoto, Y Tokunaga et al.
Ephrin (EFN) and Eph receptor (EPH) genes in atherosclerosis
expression of the human EFN and EPH
family of genes.
EFN AND EPH EXPRESSION IN
MONOCYTES AND THP-1 CELLS
In adult human peripheral blood monocytes,
multiple EFN and EPH genes of both the A
and the B subclasses were detected. All EFN
and EPH genes were detected except those
coding for ephrin A2, EphA3 and EphA7 and
ephrin B3 (Fig. 1, monocytes, × 35). Strong
signals were observed for the genes coding for
ephrin A4 and EphB2, EphB4 and EphB6 (Fig.
1, monocytes, × 30). In human monocytic
THP-1 cells, all EFN and EPH genes were
found except those coding for EphA3, EphA4
and EphA8 (Fig. 1, THP-1, × 35) and robust
signals were obtained for the genes coding for
ephrin A4, EphA6, EphB1, EphB4 and EphB6
(Fig. 1, THP-1, × 30). The expression patterns
of the EFN and EPH genes in adult human
monocytes and THP-1 cells showed
similarities, though with some disparities
which might have been due to immortalizing
processes occurring in THP-1 cells.10
EFN AND EPH EXPRESSION IN
HCAEC AND JURKAT T CELLS
Multiple members of the A and B subclasses
of EFN and EPH genes were also detected in
HCAEC and Jurkat T cells. In HCAEC, all
members except the genes coding for EphA1
FIGURE 1: Expression profiling of genes encoding ephrin cell signalling peptides and
their cognate ephrin receptors in adult human peripheral blood monocytes, THP-1
cells, adult human coronary artery endothelial cells (HCAEC) and Jurkat T cells by
reverse transcription–polymerase chain reaction (RT–PCR). The templates used were:
lanes 1, cDNA; lanes 2, DNA-cleared RNA; lanes 3, genomic DNA and the PCR was
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and EphB3 were found (Fig. 1, endothelial
cells, × 35) and strong signals were detected
for the genes coding for ephrins A1, A4 and
A5, EphA2 and EphA4, ephrins B1 and B2,
and EphB1, EphB2 and EphB4 (Fig. 1,
endothelial cells, × 30). In Jurkat T cells, all
members except the genes coding for ephrins
A2 and A5, EphA4, EphA7 and EphB3 were
detected (Fig. 1, Jurkat, × 35) and robust
bands were obtained for the genes coding for
ephrins A1, A3 and A4, EphA3, ephrins B1
and B2, EphB1, EphB2, EphB4 and EphB6
(Fig. 1, Jurkat, × 30). The pattern of
redundant expression of EFN and EPH genes
in HCAEC and Jurkat T cells was consistent
with previous reports.11,12
Discussion
Ephrins are divided into two subclasses
according to the way in which they are
bound to the cell membrane: those of
subclass A (ephrins A1 – A5) are attached to
the plasma membrane by a
glycosylphosphatidylinositol anchor,
whereas those of subclass B (ephrins B1 – B3)
have a single transmembrane domain.3,4
Ephrins of subclasses A and B interact
primarily with Eph receptors of subclasses A
(EphA1 – EphA8) and B (EphB1 – EphB4 and
EphB6), respectively. Characteristically,
ephrins and Eph receptors can mediate
bidirectional signalling: classical forward
signalling by Eph receptors via their intrinsic
tyrosine kinase activity and reverse
signalling by ephrins of subclass B via their
conserved cytoplasmic domain.3 Despite
intensive study, the significance of ephrins
and Eph receptors in adults is still unclear.
We previously reported that ephrin B1 and
EphB2 were expressed in both dilated and
stenotic lesions associated with
atherosclerosis.5 In the inflammatory process,
monocytes adhere to endothelial cells during
transmigration13 and to T lymphocytes as
antigen-presenting macrophages.14 Through
these cell-to-cell interactions, ephrins and Eph
receptors on monocytes/macrophages can
bind to their counterparts on other types of
cell or to other monocytes/macrophages.
Ephrin B1 and reverse signalling by EphB2
inhibit monocyte chemotaxis.5 Several
ephrins of both subclasses A and B can inhibit
the chemotaxis of Jurkat T cells12 and ephrin
B1 promotes endothelial cell migration.15
These findings suggest that a wide variety
of ephrins and Eph receptors might
modulate the chemokine-conditioned
transmigration/chemotaxis of monocytes.9
The ephrin/Eph receptor system might
provide clues about the regulatory
mechanisms of monocytes/macrophages
and the mechanisms underlying other
macrophage-related inflammatory diseases
in adults,16 – 20 and requires further study.
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